EN DE
STOCK COMPARISON

Isofol Medical AB vs China National Uranium Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how Isofol Medical AB (ISOFOL) and China National Uranium Co (001280) compare, as of Aug 26, 2026.

As of Aug 26, 2026, Fair Value Calculator sees Isofol Medical AB as the less overvalued of the two: Isofol Medical AB trades at SEK 0.84 versus a fair value of SEK 0.29 (-66%), while China National Uranium Co trades at ¥68.87 versus ¥14.20 (-79%).
Isofol Medical AB
ISOFOL.ST · SEK · Health Care
-66%
upside to fair value
overvalued
PriceSEK 0.84
Fair ValueSEK 0.29
Quality41/100
China National Uranium Co
001280.SHE · CNY · Industrials
-79%
upside to fair value
overvalued
Price¥68.87
Fair Value¥14.20
Quality41/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Isofol Medical ABChina National Uranium Co
Valuation
P/E (TTM)62.3×
P/S (TTM)6.78×
0.24×P/B6.93×
EV/EBITDA48.5×
Dividend yield0.1%
Profitability
0%Net margin8%
0%Operating margin14%
-71%Return on equity16%
-36%Return on assets6%
Growth
Revenue growth (YoY)0%
-73.1%Avg. growth/yr (3Y)23.6%
Balance & size
Debt / equity0.22×
$26MMarket cap$17B
weakGrowth qualityexpensive

China National Uranium Co leads: 1 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Isofol Medical ABof which business quality 41 · market factors 50 China National Uranium Coof which business quality 41 · market factors 24
ProfitabilityMargins and returns on capital today
0
38
Quality GrowthAre margins and returns improving?
62
47
CashflowEarnings quality: real cash, not paper profit
31
0
Fin. StrengthBalance sheet, leverage, solvency risk
75
89
InvestmentDisciplined investing over empire-building
100
21
Low VolatilityCalm price path (market factor)
35
16
MomentumPrice trend over the last 3–12 months (market factor)
65
26
52W MomentumDistance to the 52-week high (market factor)
43
30
Net IssuanceBuybacks instead of dilution
0
47

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Isofol Medical AB

Asset-BasedSEK 0.23

1 of 1 models see the stock below the current price.

China National Uranium Co

DCF Models¥5.99
Earnings-Based¥15.53
Dividend Discount¥1.14
Multiples¥18.09
Asset-Based¥5.47
Economic Profit¥15.54
Growth Earnings¥21.36

17 of 17 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Isofol Medical AB
Bear SEK 0.19Fair Value SEK 0.29Bull SEK 0.36
SEK 0.84 = current price (white tick)
China National Uranium Co
Bear ¥10.65Fair Value ¥14.20Bull ¥17.75
¥68.87 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Isofol Medical AB · Health Care

Quality score41 · below median
Fair value upside-66% · bottom 25%

China National Uranium Co · Industrials

Quality score41 · bottom 25%
Fair value upside-79% · bottom 25%

Bottom line

As of Aug 26, 2026, Fair Value Calculator sees Isofol Medical AB as the less overvalued of the two: Isofol Medical AB trades at SEK 0.84 versus a fair value of SEK 0.29 (-66%), while China National Uranium Co trades at ¥68.87 versus ¥14.20 (-79%).

Isofol Medical AB has the higher quality score (41/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.